Sigal-Zafrani B - Search Results

1

Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial.

Valet F, de Cremoux P, Spyratos F, Servant N, Dujaric ME, Gentien D, Lehmann-Che J, Scott V, Sigal-Zafrani B, Mathieu MC, Bertheau P, Guinebretière JM, Pierga JY, Delaloge S, Giacchetti S, Brain E, Tembo O, Marty M, Asselain B. Valet F, et al. Breast. 2013 Dec;22(6):1052-9. doi: 10.1016/j.breast.2013.08.015. Epub 2013 Oct 2. Breast. 2013. PMID: 24095610 Free article. Clinical Trial.

2

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.

Hamy AS, Bieche I, Lehmann-Che J, Scott V, Bertheau P, Guinebretière JM, Matthieu MC, Sigal-Zafrani B, Tembo O, Marty M, Asselain B, Spyratos F, de Cremoux P. Hamy AS, et al. Among authors: sigal zafrani b. Breast Cancer Res Treat. 2016 Oct;159(3):499-511. doi: 10.1007/s10549-016-3961-2. Epub 2016 Sep 3. Breast Cancer Res Treat. 2016. PMID: 27592112

3

Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age.

Pierga JY, Girre V, Laurence V, Asselain B, Diéras V, Jouve M, Beuzeboc P, Fourquet A, Nos C, Sigal-Zafrani B, Pouillart P; Institut Curie Breast Cancer Study Group. Pierga JY, et al. Breast. 2004 Oct;13(5):369-75. doi: 10.1016/j.breast.2004.04.012. Breast. 2004. PMID: 15454191

4

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.

de Cremoux P, Bieche I, Tran-Perennou C, Vignaud S, Boudou E, Asselain B, Lidereau R, Magdelénat H, Becette V, Sigal-Zafrani B, Spyratos F. de Cremoux P, et al. Endocr Relat Cancer. 2004 Sep;11(3):489-95. doi: 10.1677/erc.1.00808. Endocr Relat Cancer. 2004. PMID: 15369450

5

Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatment.

Salmon RJ, Alran S, Malka I, de Cremoux P, Rosty C, Languille O, Campana F; Breast Group of the Institut Curie; Sigal-Zafrani B. Salmon RJ, et al. Am J Clin Oncol. 2006 Aug;29(4):385-8. doi: 10.1097/01.coc.0000225397.24909.33. Am J Clin Oncol. 2006. PMID: 16891867 Clinical Trial.

6

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies.

Bollet MA, Savignoni A, Pierga JY, Lae M, Fourchotte V, Kirova YM, Dendale R, Campana F, Sigal-Zafrani B, Salmon R, Fourquet A, Vincent-Salomon A. Bollet MA, et al. Br J Cancer. 2008 Feb 26;98(4):734-41. doi: 10.1038/sj.bjc.6604229. Epub 2008 Feb 5. Br J Cancer. 2008. PMID: 18253121 Free PMC article.

7

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.

Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Diéras V, Mathiot C, Mignot L, Thiery JP, Sastre-Garau X, Pierga JY. Bidard FC, et al. Ann Oncol. 2008 Mar;19(3):496-500. doi: 10.1093/annonc/mdm507. Epub 2008 Jan 10. Ann Oncol. 2008. PMID: 18187488 Free article.

8

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.

Daveau C, Baulies S, Lalloum M, Bollet M, Sigal-Zafrani B, Sastre X, Vincent-Salomon A, Tardivon A, Thibault F, Pierga JY, Cottu P, Sablin MP, Rouzier R, Malhaire C, Mallon P, Reyal F. Daveau C, et al. Br J Cancer. 2014 Apr 29;110(9):2195-200. doi: 10.1038/bjc.2014.143. Epub 2014 Apr 8. Br J Cancer. 2014. PMID: 24714751 Free PMC article.

9

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.

Mouttet D, Laé M, Caly M, Gentien D, Carpentier S, Peyro-Saint-Paul H, Vincent-Salomon A, Rouzier R, Sigal-Zafrani B, Sastre-Garau X, Reyal F. Mouttet D, et al. Among authors: sigal zafrani b. PLoS One. 2016 Feb 1;11(2):e0146474. doi: 10.1371/journal.pone.0146474. eCollection 2016. PLoS One. 2016. PMID: 26829108 Free PMC article.

10

Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?

Sigal-Zafrani B, Bollet MA, Antoni G, Savignoni A, Vincent-Salomon A, Pierga JY, Salmon R, Sastre-Garau X, Fourquet A. Sigal-Zafrani B, et al. Br J Cancer. 2007 Oct 22;97(8):1046-52. doi: 10.1038/sj.bjc.6603991. Epub 2007 Sep 18. Br J Cancer. 2007. PMID: 17876326 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters